BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6124598)

  • 1. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1980; 68(3):261-7. PubMed ID: 6248916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1981; 73(1):97-8. PubMed ID: 6262850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
    Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of brain histamine in delta 9-tetrahydrocannabinol tolerance and withdrawal.
    Verberne AJ; Fennessy MR; Lewis SJ; Taylor DA
    Pharmacol Biochem Behav; 1985 Aug; 23(2):153-9. PubMed ID: 2997805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
    Davies JA; Graham JD
    Psychopharmacology (Berl); 1980; 69(3):299-305. PubMed ID: 6251505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
    Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
    Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
    Coupar IM; Taylor DA
    Br J Pharmacol; 1982 May; 76(1):115-9. PubMed ID: 6282371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of (-)-trans-delta 9-tetrahydrocannabinol on regional brain levels and subcellular distribution of monoamines in the rat.
    Taylor DA; Fennessy MR
    Clin Exp Pharmacol Physiol; 1979; 6(5):541-8. PubMed ID: 498594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of physical dependence on cyclazocine and pentazocine in the rat.
    Laska FJ; Fennessy MR
    Eur J Pharmacol; 1978 Mar; 48(1):57-65. PubMed ID: 565289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat.
    Mokler DJ; Robinson SE; Johnson JH; Hong JS; Rosecrans JA
    Neurotoxicol Teratol; 1987; 9(4):321-7. PubMed ID: 2446111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.
    Miczek KA; Dixit BN
    Psychopharmacology (Berl); 1980 Feb; 67(2):195-202. PubMed ID: 6245424
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
    Englert LF; Ho BT; Taylor D
    Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol.
    Fitton AG; Pertwee RG
    Br J Pharmacol; 1982 Feb; 75(2):409-14. PubMed ID: 6313110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
    Finn DP; Beckett SR; Roe CH; Madjd A; Fone KC; Kendall DA; Marsden CA; Chapman V
    Eur J Neurosci; 2004 Feb; 19(3):678-86. PubMed ID: 14984418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.